MRSA Notes

In a gesture of good will and marketing sense, PURE Bioscience has donated 200 gallons of its new silver-based high performance, low toxicity disinfectant, Staph Attack, to the City of San Diego’s First Responders. They have led the horse to water, let’s pray that they take a drink. Then invite their other horsey friends over for a drink. You can read the whole press release, with information about the donation and more about how the product works, after the jump.

Company and City Aim to Fight Growing Problem of MRSA - a Potentially
Deadly Form of Staph Infection

SAN DIEGO, Jan. 30 /PRNewswire-FirstCall/ — PURE Bioscience (OTC
Bulletin Board: PURE) today announced a donation of 200 gallons of Staph
Attack(TM) the silver-based hard surface disinfectant created by PURE
Bioscience and distributed by Enviroguard Technologies LLC specifically for
populations where resistant bacteria are becoming increasingly problematic,
e.g. hospitals, prisons, schools, etc. Staph Attack carries EPA-registered
claims against Methicillin-resistant Staphylococcus aureus (MRSA), while
maintaining the Category IV lowest-toxicity EPA rating.
(Logo: http://www.newscom.com/cgi-bin/prnh/20060119/LATH060LOGO)
PURE Bioscience recently learned of an increasingly problematic MRSA
issue, (a form of staph infection particularly difficult to treat due to
its resistance to antibiotics) among San Diego’s homeless and by extension
with the emergency responders in San Diego working to help these
individuals. In an effort to supplement current city safeguards to stop the
spread of the highly contagious infection, PURE is donating 800 bottles of
Staph Attack, enough to treat 72,000 square feet of hard surfaces, for use
by EMT, Fire Department, and Police personnel in the city of San Diego.
“We greatly appreciate a local company stepping forward to help address
a serious health threat in our city,” stated San Diego Fire Chief Tracy
Jarman. “Anything we can do to stop the spread of MRSA by creating a
cleaner environment for the individuals coming into contact with the
infection on a daily basis is a great asset not only to our teams but to
public health as a whole.”
“Staph Attack has been successful in eradicating MRSA in public and
governmental areas in other cities,” stated Michael L. Krall, President and
CEO PURE Bioscience. “We are grateful to be able to provide this solution
to our own city and first responders.”
PURE’s CEO, Michael L. Krall will present the donation to Dr. James
Dunford, San Diego City Medical Director and Rod Ballard, Deputy Chief of
the San Diego Fire-Rescue Department and President of San Diego Medical
Services Enterprise today, at 2pm at San Diego Fire Rescue storeroom 42
located at, 3750 Kearny Villa Rd. San Diego, California.
How does it work? Silver dihydrogen citrate (SDC), the patented active
ingredient in Staph Attack, is an electrolytically generated source of
stabilized ionic silver. In one of the mechanisms of action, the bacteria
views the molecule as a food source, and once the organism consumes it, SDC
destroys the bacteria by disabling proteins and halting its metabolic and
reproductive functions. SDC provides 24-hour residual protection as well.
SDC, a new molecular entity, is distinguished from competitors because
of its superior efficacy and reduced toxicity. PURE produces and markets
ready-to-use EPA-registered disinfectant products, as well as varying
strengths of SDC concentrate as an active ingredient, additive or
preservative for inclusion in third party products. PURE also pursues
development programs for SDC as an active pharmaceutical ingredient in a
variety of pharmaceutical products.
Staph Attack is currently available through its distributor,
Enviroguard Technologies, LLC (http://www.enviroguardtech.net).
About PURE Bioscience
PURE Bioscience (PURE) develops and markets technology-based bioscience
products that provide solutions to numerous global health challenges.
PURE’s proprietary high efficacy/low toxicity bioscience technologies,
including its silver dihydrogen citrate-based antimicrobials and boric
acid-based pesticides, represent innovative advances in diverse markets and
lead today’s global trend toward industry and consumer use of “green”
products while providing competitive advantages in efficacy and safety.
PURE Bioscience, headquartered in El Cajon, California, (San Diego
metropolitan area), was incorporated in 1992. For additional information on
PURE Bioscience, visit the Company’s website: http://www.purebio.com.
This press release includes statements that may constitute
“forward-looking” statements, usually containing the words “believe,”
“estimate,” “project,” “expect” or similar expressions. These statements
are made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements inherently
involve risks and uncertainties that could cause actual results to differ
materially from the forward-looking statements. Factors that would cause or
contribute to such differences include, but are not limited to, acceptance
of the Company’s current and future products and services in the
marketplace, the ability of the Company to develop effective new products
and receive regulatory approvals of such products, competitive factors,
dependence upon third-party vendors, and other risks detailed in the
Company’s periodic report filings with the Securities and Exchange
Commission. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions or
changes after the date of this release.
Media Contact: Investor Contact:
Karen Sparks, Mentus Terri MacInnis, Bibicoff & Associates, Inc.
(858) 455-5500 (818) 379-8500
karen@mentus.com terrimac@bibicoff.com

Awareness, California, Infection Prevention, MRSA, MRSA in the U.S., PR & Media

Share This